Publication:

CNS immune surveillance and neuroinflammation: endocannabinoids keep control

Date

Date

Date
2008
Journal Article
Published version

Citations

Citation copied

Wolf, S. A., Tauber, S., & Ullrich, O. (2008). CNS immune surveillance and neuroinflammation: endocannabinoids keep control. Current Pharmaceutical Design, 14(23), 2266–2278. https://doi.org/10.2174/138161208785740090

Abstract

Abstract

Abstract

To avoid inflammatory escalation, the central nervous system (CNS) harbors an impressive arsenal of cellular and molecular mechanisms enabling strict control of immune reactions. We here summarize studies suggesting that the old paradigm of the "CNS immune privilege" is overly simplistic. The immune system is allowed to keep the CNS under surveillance, but in a strictly controlled, limited and well-regulated manner. The first line of defense lies outside the brain parenchyma to spare neuronal tissue from the detrimental effects of an

Metrics

Views

118 since deposited on 2009-03-04
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Wolf, S A
    affiliation.icon.alt
  • Tauber, S
    affiliation.icon.alt
  • Ullrich, O
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
14

Number

Number

Number
23

Page range/Item number

Page range/Item number

Page range/Item number
2266

Page end

Page end

Page end
2278

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2008

Date available

Date available

Date available
2009-03-04

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1381-6128

OA Status

OA Status

OA Status
Closed

PubMed ID

PubMed ID

PubMed ID

Metrics

Views

118 since deposited on 2009-03-04
Acq. date: 2025-11-12

Citations

Citation copied

Wolf, S. A., Tauber, S., & Ullrich, O. (2008). CNS immune surveillance and neuroinflammation: endocannabinoids keep control. Current Pharmaceutical Design, 14(23), 2266–2278. https://doi.org/10.2174/138161208785740090

Closed
Loading...
Thumbnail Image

Permanent URL

Permanent URL

Permanent URL
No files available